Group One Trading, L.P. Pds Biotechnology Corp Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 8,481 shares of PDSB stock, worth $26,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,481
Previous 30,456
72.15%
Holding current value
$26,036
Previous $120,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PDSB
# of Institutions
80Shares Held
5.47MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$4.33 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.49 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.16 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC360KShares$1.1 Million0.16% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $87.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...